AVY vs EW · P/E 17, rev $8.76B vs P/E 47, rev $1.39B
Avery Dennison Corp (AVY) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Avery Dennison Corp (AVY) is a packaging & containers company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AVY revenue for 2024-12-28 was $8.76B. Net income was $704.9M. Revenue was up 4.7% from 2023-12-30 to 2024-12-28. AVY currently screens at market cap $11.87B and trailing P/E 17.5.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AVY currently screens at market cap $11.87B and trailing P/E 17.5. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AVY and EW stock pages for the full models.
Not investment advice.